Device / Technology News

RSS

CLEAR study meets primary endpoint: Sorin Group

Sorin Group, a global leader in the treatment of cardiovascular diseases, announced today that the CLEAR study has met its primary endpoint.

18 Jun 2010

Medical Simulation announces new agreement with New York's North Shore-LIJ Health System

Medical Simulation Corporation (MSC) proudly announces a new agreement with the North Shore-LIJ Health System, New York's largest health system and recipient of the 2010 National Quality Healthcare Award from the National Quality Forum. The agreement includes the sale of MSC's endovascular simulation system, Simantha®, and licensing of MSC's curriculum and training services to advance North Shore's education and patient safety goals over the next three years.

18 Jun 2010

Gen-Probe invests $50M in Pacific Biosciences

Gen-Probe Incorporated and Pacific Biosciences announced today that Gen-Probe has made a $50 million strategic investment in Pacific Biosciences, a private sequencing company. In addition, the companies will work together to explore co-development of new integrated clinical diagnostics systems based on Pacific Biosciences' Single Molecule Real Time (SMRT™) platform and Gen-Probe's expertise in diagnostics.

18 Jun 2010

Health IT implementation plan: 'Bold incrementalism'

Farzad Mostashari, a senior official in the government's health IT office, said in a speech Tuesday that the strategy for implementing federal ehealth efforts is one of "bold incrementalism," Modern Healthcare reports. Mostashari listed as an example the Office of the National Coordinator for Health IT's "approach to the health information exchange.

18 Jun 2010

Phylogeny, Neoprobe announce collaboration to develop head and neck cancer detection technology

Phylogeny, the in situ company, and Neoprobe, a diversified developer of innovative biomedical surgical oncology products, announce their collaboration to develop head and neck cancer detection technology.

18 Jun 2010

St. Jude Medical commences enrollment in LAPTOP-HF study

St. Jude Medical, Inc., a global medical device company, today announced the first enrollment in its LAPTOP-HF (Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy) study. The goal of the LAPTOP-HF study is to demonstrate that the new investigational left atrial pressure (LAP) management system safely and effectively improves outcomes in patients with heart failure (HF).

17 Jun 2010

Nineteen facilities named Centers of Excellence in APBI for use of SAVI applicator

Nineteen facilities in the Mid-Atlantic region have been named Centers of Excellence in accelerated partial breast irradiation for their use of the SAVI applicator, an advanced therapy for breast cancer as part of breast conservation therapy. The SAVI applicator can provide important advantages for women with early-stage breast cancer.

17 Jun 2010

First implantation of PyroTITAN Humeral Resurfacing Arthroplasty performed outside US in Australia

Ascension Orthopedics, Inc., a market leader in PyroCarbon orthopedic implants, announces the first implantation of the PyroTITAN™ Humeral Resurfacing Arthroplasty outside the United States. The PyroTITAN was implanted last month in Brisbane, Australia in a 46-year-old patient who reported "immediate pain relief" within 24 hours of surgery. The PyroTITAN Humeral Resurfacing implant is the first commercially-available shoulder arthroplasty prosthesis made of PyroCarbon in the world.

17 Jun 2010

Benefitfocus announces acquisition of BeliefNetworks

Benefitfocus today announced the acquisition of BeliefNetworks, Inc., a leader in transforming real-time data – including consumer behavior, marketing campaign data and social networking conversations – into actionable knowledge for customers. The agreement includes three patent applications and proprietary software code. These assets and the highly-experienced staff of BeliefNetworks are a valuable addition to Benefitfocus, the leader in Software as a Service solutions for health and voluntary benefits.

17 Jun 2010

MicroPulse protocol as effective as ETDRS in treatment of DME: Study

IRIDEX Corporation announced the recent publication of a clinical study comparing results obtained in the treatment of diabetic macular edema (DME) using an IRIDEX laser and MicroPulse™ treatment protocol to those obtained using the recognized standard of care Early Treatment of Diabetic Retinopathy Study (ETDRS) laser protocol.

17 Jun 2010

Kennedy Krieger Institute orders for Bruker's ultra-high field MRI CryoProbe

Bruker has received an order for the first ultra-high field MRI CryoProbe in North America to be installed at the F.M. Kirby Research Center for Functional Brain Imaging at the Kennedy Krieger Institute in Baltimore, MD. Supported by an American Recovery and Reinvestment Act (ARRA) award to Dr. Peter van Zijl, Director of the Center, the 500 MHz MRI CryoProbe is part of an ultra-high field preclinical MRI BioSpec® system that includes an 11.7 T UltraShield Refrigerated (USR™) magnet and AVANCE™ III electronics.

17 Jun 2010

BIOTRONIK receives first-ever Cardiostim Innovation Award

BIOTRONIK SE & Co. KG, has achieved another milestone confirming yet again that it is the industry-leading pioneer in wireless remote monitoring technology for patients with cardiac devices, having yesterday received the first-ever Cardiostim Innovation Award.

17 Jun 2010

St. Jude Medical's EnSite Contact Technology platform receives European CE Mark approval

St. Jude Medical, Inc., a global medical device company, today announced European CE Mark approval of the EnSite Contact™ Technology platform at the 17th World Congress in Cardiac Electrophysiology and Cardiac Techniques (CardioStim).

17 Jun 2010

FDA seeks public input on regulation of laboratory-developed tests

The U.S. Food and Drug Administration today announced plans to hold a public meeting on July 19-20, 2010, to discuss how the agency will oversee laboratory-developed tests (LDTs).

17 Jun 2010

dabl's computerised system prevents misdiagnosis of ABPM

An independent study has revealed that Irish Company, dabl's computerised system for diagnosing 24 hour blood pressure is more accurate and consistent than a leading group of international hypertension experts.

17 Jun 2010

New legislation will impede use of MRI in medical research

Europe must act to prevent new legislation impeding the use of magnetic resonance imaging (MRI) in medical research, diagnosis and treatment, states the European Science Foundation (ESF) in a new report. The report is endorsed by the European Medical Research Councils, representing the medical research communities in 30 countries.

17 Jun 2010

Micrus Endovascular receives approval to market DeltaPaq, DeltaPlush microcoils for cerebral aneurysms in Japan

Micrus Endovascular Corporation today announced receipt of Shonin approval from the Ministry of Health, Labour and Welfare to market in Japan its novel bare platinum and Cerecyte® DeltaPaq™ filling and DeltaPlush™ finishing microcoils for the treatment of cerebral aneurysms and treatments in the peripheral vasculature.

17 Jun 2010

Bacterin International to distribute biologic products to Broadlane network of medical institutions

Bacterin International, Inc., a developer of revolutionary bone graft material, today announced a three-year agreement to provide its biologic line of products, OsteoSponge®, OsteoSelect®, OsteoSponge SC®, OsteoWrap®, BacFast®, and OsteoLock®, to the vast Broadlane® nationwide network of hospitals and medical practices.

17 Jun 2010

Positive results from Cytomedix's AutoloGel System study for treatment of advanced, chronic wounds published

Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that positive results from a prospective study evaluating the AutoloGel™ System to treat advanced, chronic wounds was published in the June 2010 issue of Ostomy Wound Management in a peer reviewed article entitled, "Chronic Wounds Treated With a Physiologically Relevant Concentration of Platelet-rich Plasma (PRP) Gel: A Prospective Case Series."

17 Jun 2010

TechniScan launches clinical study of Warm Bath Ultrasound system in Rochester

TechniScan, a medical device company engaged in the development and commercialization of an automated 3D breast ultrasound imaging system, today announced that it has launched a clinical study in Rochester, Minn., its third new clinical site to commence in the last five months.

17 Jun 2010

Device / Technology News

CLEAR study meets primary endpoint: Sorin Group

Medical Simulation announces new agreement with New York's North Shore-LIJ Health System

Gen-Probe invests $50M in Pacific Biosciences

Health IT implementation plan: 'Bold incrementalism'

Phylogeny, Neoprobe announce collaboration to develop head and neck cancer detection technology

St. Jude Medical commences enrollment in LAPTOP-HF study

Nineteen facilities named Centers of Excellence in APBI for use of SAVI applicator

First implantation of PyroTITAN Humeral Resurfacing Arthroplasty performed outside US in Australia

Benefitfocus announces acquisition of BeliefNetworks

MicroPulse protocol as effective as ETDRS in treatment of DME: Study

Kennedy Krieger Institute orders for Bruker's ultra-high field MRI CryoProbe

BIOTRONIK receives first-ever Cardiostim Innovation Award

St. Jude Medical's EnSite Contact Technology platform receives European CE Mark approval

FDA seeks public input on regulation of laboratory-developed tests

dabl's computerised system prevents misdiagnosis of ABPM

New legislation will impede use of MRI in medical research

Micrus Endovascular receives approval to market DeltaPaq, DeltaPlush microcoils for cerebral aneurysms in Japan

Bacterin International to distribute biologic products to Broadlane network of medical institutions

Positive results from Cytomedix's AutoloGel System study for treatment of advanced, chronic wounds published

TechniScan launches clinical study of Warm Bath Ultrasound system in Rochester

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News